Physician profile

Candace Klein

Nurse Anesthetist, Certified Registered · Fort Myers, FL

NPI 1023247889

$83.94

in general payments reported to CMS, 2019-2025

2 companies · $83.94 in 2025

The $83.94 reported for 2025 was more than what a typical Nurse Anesthetist, Certified Registered provider received nationally (typical 2025 total: $45.72).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$83.94

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Janssen Biotech, INC. $42.74 2025 Tremfya
Ardelyx, INC. $41.20 2025 Ibsrela

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Candace Klein

$83.94

in general payments reported 2019-2025

Years
2025
Top company
Janssen Biotech, INC.
Context
The $83.94 reported for 2025 was more than what a typical Nurse Anesthetist, Certified Registered provider received nationally (typical 2025 total: $45.72).

https://glasscript.com/doctor/10754999/candace-klein

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.